Vivos (RDGL) Return on Capital Employed (2011 - 2025)
Vivos recorded quarterly Return on Capital Employed of 161.19% in Q4 2025, down 42.99% quarter-over-quarter from 112.73% in Q3 2025, and down 361.0% year-over-year from 61.76% in Q4 2024.
Vivos' Return on Capital Employed history runs 15 years deep, the most recent figure standing at 161.19% for Q4 2025.
- In Q4 2025, Return on Capital Employed fell 361.0% year-over-year to 161.19%; the TTM figure through Dec 2025 stood at 161.19% (down 361.0% YoY), while the FY2025 annual figure was 163.77%, down 2189.0% from the prior year.
- Return on Capital Employed came in at 161.19% for Q4 2025 at Vivos, down from 112.73% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 75.62% in Q1 2021 to a low of 219.63% in Q1 2024.
- A 5-year average of 156.53% and a median of 153.6% in 2021 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed sank 31454 bps in 2021 and jumped 11064 bps in 2025, its largest moves.
- Vivos' Return on Capital Employed stood at 149.62% in 2021, then increased by 7 bps to 138.89% in 2022, then tumbled by 50 bps to 207.93% in 2023, then gained by 24 bps to 157.59% in 2024, then dropped by 2 bps to 161.19% in 2025.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 161.19%, 112.73%, and 103.43% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Vivos | - | - | -3,105.00 | -161.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -161.19% |
| Sep 30, 2025 | -112.73% |
| Jun 30, 2025 | -103.43% |
| Mar 31, 2025 | -108.99% |
| Dec 31, 2024 | -157.59% |
| Sep 30, 2024 | -197.88% |
| Jun 30, 2024 | -193.68% |
| Mar 31, 2024 | -219.63% |
| Dec 31, 2023 | -207.93% |
| Sep 30, 2023 | -162.73% |
| Jun 30, 2023 | -141.81% |
| Mar 31, 2023 | -129.96% |
| Dec 31, 2022 | -138.89% |
| Sep 30, 2022 | -143.38% |
| Jun 30, 2022 | -196.20% |
| Mar 31, 2022 | -217.54% |
| Dec 31, 2021 | -149.62% |
| Sep 30, 2021 | -169.77% |
| Jun 30, 2021 | -142.05% |
| Mar 31, 2021 | -75.62% |
| Dec 31, 2020 | 164.92% |
| Sep 30, 2020 | 93.65% |
| Dec 31, 2019 | 94.79% |
| Sep 30, 2019 | 215.35% |
| Jun 30, 2019 | 184.12% |
| Mar 31, 2019 | 227.68% |
| Dec 31, 2018 | 263.58% |
| Sep 30, 2018 | 4.14% |
| Jun 30, 2018 | 21.19% |
| Mar 31, 2018 | 49.98% |
| Dec 31, 2017 | 61.49% |
| Sep 30, 2017 | 53.85% |
| Jun 30, 2017 | 45.89% |
| Mar 31, 2017 | 128.97% |
| Dec 31, 2016 | 147.75% |
| Sep 30, 2016 | 138.33% |
| Jun 30, 2016 | 111.08% |
| Mar 31, 2016 | 17.67% |
| Dec 31, 2015 | 20.83% |
| Sep 30, 2015 | 15.26% |
| Jun 30, 2015 | 9.86% |
| Mar 31, 2015 | 8.21% |
| Dec 31, 2014 | 9.71% |
| Sep 30, 2014 | 21.18% |
| Jun 30, 2014 | 20.45% |
| Mar 31, 2014 | 28.02% |
| Dec 31, 2013 | 40.65% |
| Sep 30, 2013 | 55.83% |
| Jun 30, 2013 | 84.69% |
| Mar 31, 2013 | 96.20% |
| Dec 31, 2012 | 72.81% |
| Sep 30, 2012 | 118.41% |
| Jun 30, 2012 | 74.23% |
| Mar 31, 2012 | 53.06% |
| Dec 31, 2011 | 61.28% |
| Sep 30, 2011 | 92.61% |